Regulates the sale of methamphetamine precursor drugs

This bill regulates the sale of products containing ephedrine or pseudoephedrine (common methamphetamine precursors) by pharmacies and retailers. It sets daily purchase limits (3.6 grams) and 30-day limits (9 grams), requires ID checks and detailed purchase logging at checkout, and mandates real-time electronic tracking to block sales exceeding limits. Retailers must display these products behind counters, and the system includes an override for emergencies while logging all exceptions. Violations incur fines (up to $1,000 per violation), and the law preempts local regulations while exempting prescription purchases and specially certified products.